ArticleCureus2025
Neurotrophic Keratitis Following Vitrectomy Surgery: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Exosome-based therapies for corneal disorders: current status and future perspectives.MedScience · 2026Review
- The Therapeutic Potential of Insulin Eye Drops in Neurotrophic Keratopathy: A Comprehensive Review.Biomedicines · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neurotrophic keratitis is a rare corneal degenerative disorder characterized by decreased sensory innervation, leading to epithelial defects and impaired wound healing. This report presents a case of a 60-year-old female with a history of type 2 diabetes and prior herpes infection who developed neurotrophic keratitis following ocular surgery for proliferative diabetic retinopathy. Initial treatment targeted infectious keratitis; however, persistent symptoms prompted a revised diagnosis. Management with autologous serum drops resulted in partial resolution of the epithelial defect but left a central leucoma and severely reduced visual acuity. This case highlights the need for early diagnosis and targeted therapy to prevent irreversible corneal damage in patients with high-risk profiles.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.